Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-12-333623
Filing Date
2012-08-03
Accepted
2012-08-03 09:34:45
Documents
2
Effectiveness Date
2012-08-03

Document Format Files

Seq Description Document Type Size
1 SOLICITING MATERIAL d390941ddefa14a.htm DEFA14A 23834
2 GRAPHIC g390941g21m41.jpg GRAPHIC 11651
  Complete submission text file 0001193125-12-333623.txt   41324
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35285 | Film No.: 121005394
SIC: 2836 Biological Products, (No Diagnostic Substances)